Objective
"Osteoarthritis (OA) is the most common musculoskeletal disorder and affects approximately 355 million people world-wide. At present, no definitive cure exists for OA. Current treatment involves total joint replacement (TJR) which accounts for approximately 35% of arthritis related procedures. Presently more than 200,000 total knee replacements and 70,000 total hip replacements procedure are performed annually in the UK. One of the key aspects contributing to successful fixation is the rapid and complete integration of the device with bone (osseointegration). Without this biological reaction, stability is compromised potentially resulting in aseptic loosening which generally requires revision surgery. This can be detrimental for OA patients as the quality of bone is compromised, therefore, the potential for adequate implant stabilisation is substantially reduced. Several studies have identified the surface properties of an implant as being a major determinant of osseointegration. The addition of coatings have attracted interest, however, a major stumbling block for reliable application of coating technologies is potential failure during long-term implantation. Recent data suggests that impaired peri-implant osseointegration is associated with declined osteoprogenitor recruitment. The scientific objective of this project is to identify a strategy for enhancing rapid osseointegration of implant devices through 1) increased recruitment and attachment and 2) modulation of mesenchymal stem cell (MSC) differentiation. To this end, we aim to develop specific cell targeting antibodies for optimal MSC recruitment and modulation of MSC differentiation for improved osteogenesis. If successful this project would achieve in providing a clinically feasible strategy for improving TJR which would directly impact several million patients annually."
Fields of science (EuroSciVoc)
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: https://op.europa.eu/en/web/eu-vocabularies/euroscivoc.
- medical and health sciences clinical medicine rheumatology
- medical and health sciences clinical medicine surgery
- medical and health sciences medical biotechnology cells technologies stem cells
- engineering and technology materials engineering coating and films
- medical and health sciences medical biotechnology implants
You need to log in or register to use this function
We are sorry... an unexpected error occurred during execution.
You need to be authenticated. Your session might have expired.
Thank you for your feedback. You will soon receive an email to confirm the submission. If you have selected to be notified about the reporting status, you will also be contacted when the reporting status will change.
Programme(s)
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Multi-annual funding programmes that define the EU’s priorities for research and innovation.
Topic(s)
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.
Call for proposal
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.
FP7-PEOPLE-2010-IEF
See other projects for this call
Funding Scheme
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.
Coordinator
H91 Galway
Ireland
The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.